跳至主要内容
临床试验/NL-OMON54708
NL-OMON54708招募中不适用

*The iLIVE medication optimisation trial* - iLIVE medication study

Erasmus MC, Universitair Medisch Centrum Rotterdam0 个研究点目标入组 110 人开始时间: 待定最近更新:

试验速览

阶段
不适用
状态
招募中
入组人数
110

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 99(—)

入选标准

  • 1. Patient is 18 years or over and provides informed consent to participate.
  • 2. The patient is aware that recovering from his/her disease is unlikely, as
  • assessed by the attending physician.
  • 3. The patient agrees to participate in the iLIVE cohort study.
  • 4. The attending physician would not be surprised if the patient were to die
  • within 6 months (*Surprise question*).
  • 5. If the physician is uncertain about the surprise question, the patient is
  • eligible if presenting with at least one SPICT indicator.
  • Relatives of included patients are asked to participate if they are:
  • 1. 18 years or over and provide informed consent to participate; aware that it
  • is unlikely that the patient will recover from his/her disease;
  • 2. capable of filling in a questionnaire in the country*s main language or in

排除标准

  • 1. The patient is incapable of filling in a questionnaire in the country*s main
  • language or in English (patients may be supported by relatives when filling in
  • the questionnaire).
  • 2. The attending physician makes the decision that the patient should not be
  • included in the study due to e.g. illness burden, fast deterioration or
  • imminent death, lack of trusting relationship with the physician.
  • Relatives are not eligible if they are incapable of filling in a questionnaire
  • in the country*s main language or in English. No more than one relative per
  • patient will be included.

研究者

相似试验